US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist

3.500
-0.165-4.50%

Close Jan 13 16:00 ET

3.480
-0.020-0.57%

Post 20:01 ET

247.06MMarket Cap-2.05P/E (TTM)

C4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

C4 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 3.333M	--
--	2024/Q4	-- / 4.333M	--
--	2024/Q3	15.362M / 4.600M	--
--	2024/Q2	12.006M / 4.783M	--
--	2024/Q1	3.039M / 9.283M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 3.333M--

--2024/Q4-- / 4.333M--

--2024/Q315.362M / 4.600M--

--2024/Q212.006M / 4.783M--

--2024/Q13.039M / 9.283M--

Unlock Free Earnings Estimates

Open Account

C4 Therapeutics Earnings Reports

C4 Therapeutics | 10-Q: Q3 2024 Earnings Report

Oct 31, 2024 07:15 ET

C4 Therapeutics | 8-K: C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Oct 31, 2024 07:11 ET

C4 Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 1, 2024 07:31 ET

C4 Therapeutics | 8-K: C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 1, 2024 07:17 ET

Analyst Rating

Updated: Jan 13, 2025

Strong Buy

Buy
75.00%
Hold
25.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall